Trial Profile
PROBE parallel group 6 wk treatment comparing telmisartan + HCT [Hydrochlorothiazide] (40/12.5mg, or 80/12.5mg) with losartan + HCT (50/12.5mg) using ABPM [ambulatory blood pressure monitoring] in Pts [patients] with mild-to moderate hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2009
Price :
$35
*
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary) ; Losartan/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 28 Mar 2007 New trial record.